The label on the attention deficit hyperactivity disorder (ADHD) drug atomoxetine hydrochloride—sold under the brand name Strattera—warns that it might cause users to suffer suicidal thoughts or liver damage. If you or your loved one has taken Strattera and you believe it caused suicidal ideations, liver damage, or some other negative side effect, you need a sympathetic advocate who will represent only your interests—and who will make the process of obtaining compensation for your injuries as painless as possible. The Rottenstein Law Group knows this, and we want you to believe it. We might be the Strattera law firm you are looking for.
What Is Strattera, and What Is It Prescribed For?
Strattera is the pharmaceutical giant Eli Lilly’s brand name for the drug atomoxetine, the only non-stimulant approved by the U.S. Food and Drug Administration (FDA) for the treatment of ADHD. Eli Lilly patented the drug in November 2002 and subsequently began selling it in oral doses from 5mg to 100mg. Because Eli Lilly recently lost a lawsuit over its Strattera patent, atomexetine is likely to become widely available in the Unites States in its generic form.
Atomexetine is a member of the class of drugs known as selective Norepinepherine Reuptake Inhibitors (NRIs). This is not to be confused with the common class of antidepressant drugs called SNRIs, Serotonin-Norepinephrine Reuptake Inhibitors. By blocking the reuptake of norepinepherine (noradrenaline) and epinephrine (adrenaline), NRIs regulate stress levels. Originally, Eli Lilly intended to use Strattera as an antidepressant, but it didn’t work in clinical trials, so Eli Lilly marketed Strattera as an ADHD drug instead.
Between 2002 and 2008 doctors prescribed Strattera to 3.3 million patients, 2 million of whom were between the ages of six and 18.
Potential Side Effects Include Liver Damage and Suicidal Thoughts
In 2005, the FDA evaluated the results of clinical trials submitted by Eli Lilly and concluded that Strattera caused increased thoughts of suicide in young people, the drug’s most common users. The trials covered 1,357 children taking atomexetine and a control group comprised of 851 people who took only a placebo. While none of the children in the control group experienced suicidal thoughts, five of the Strattera users did, including one who attempted suicide. In response to the FDA’s conclusions, Eli Lilly placed a “black box” Strattera warning on the product’s labeling. Black box warnings are the FDA’s most serious alerts.
If you or your loved one has used Strattera and suffered from suicidal thoughts or liver damage as a result, the Rottenstein Law Group would like to hear from you.
RLG’s Lawyers Will Make Things Easier
The process of demanding compensation for the harm you’ve suffered can be complicated, even if it doesn’t seem fair that you should have to go through even more trouble to be made whole again. The lawyers at the Rottenstein Law Group do everything they can to streamline the process, and they will file a Strattera lawsuit on your behalf if necessary.
If you believe you have experienced adverse side effects as a result of taking Strattera, submit this simple secure form for a free and confidential evaluation of your eligibility to file a Strattera lawsuit.